OpenAlex
PricingAboutJobs
Log inGet started
Author

Yirui Wei

Institution: The Affiliated Yongchuan Hospital of Chongqing Medical University
Observed institutions: Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing Medical University
ORCID: 0009-0001-2963-1557
Observed ORCID: 0009-0001-2963-1557
OpenAlex ID: A5101328943
Prolonged neoadjuvant hormonal therapy enhances IL-17 A/STAT3-mediated inflammation in prostate cancer
2025 · Yirui Wei, Yifan Chu, et al. · Discover Oncology · 1
PDF
Survival after neoadjuvant versus adjuvant chemotherapy in operable hormone receptor-positive HER2-negative breast cancer
2026 · Qiao Cheng, Yirui Wei, et al. · iScience
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in operable breast cancer patients with hormone receptor-positive, HER2-negative
2026 · Yirui Wei, Mengyuan Wang, et al. · Frontiers in Oncology
Hematological parameters as predictors of prostate cancer: A study based on multivariable and bidirectional Mendelian randomization
2025 · Yirui Wei, Hao Wang, et al. · Medicine
A Retrospective Cohort Study on Long-Term Results of Neoadjuvant Versus Adjuvant Chemotherapy Among HR+/HER2- Breast Cancer Patients
2025 · Lu Gan, Yirui Wei, et al. · SSRN Electronic Journal
Works count: 5
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security